摘要:目的：探討纖支鏡經口引導氣管插管在慢阻肺合并重度呼吸衰竭救治中的臨床應用價值。方法：237例慢阻肺合并重度呼吸衰竭患者,隨機分為纖支鏡經口引導氣管插管組(纖支鏡組)125例和喉鏡經口引導氣管插管組(喉鏡組)112例,分別在纖支鏡和喉鏡引導下按常規進行氣管插管術。結果：纖支鏡組和喉鏡組一次獲得插管成功率分別為984%和920%(P＜005),平均插管時間分別為（613±391） min 和（926±415） min(P＜005)。纖支鏡組有5例患者出現咽喉部少量出血,并發癥發生率為40%;喉鏡組共有12例發生并發癥,并發癥發生率為107%(P＜005),其中齒、舌、咽或喉部損傷6例,反射性嘔吐致誤吸2例,單側肺通氣1例,插入食管2例,心跳呼吸驟停1例。結論：纖支鏡經口引導氣管插管在慢阻肺合并重度呼吸衰竭救治中是一種簡便快速、成功率高和并發癥少的有效方法,值得臨床推廣應用。Abstract: Objective: To evaluate the efficacy of endotracheal intubation under fiberoptic bronchoscope through mouth in severe respiratory failure. Methods:Two hundreds and thirtyseven cases of severe respiratory failure were divided into two groups at random (fiberoptic bronchoscope group and laryngoscope group), 125 cases were intubated through mouth under fiberoptic bronchoscope, the others were intubated through mouth by laryngoscope. Results: The successful rates of endotracheal intubation were 98.4% and 92.0% in two groups respectively (P ＜005), the mean intubation timewere (613±391) min and (926±415) min respectively ( P ＜ 005), 4 cases in fiberoptic bronchoscope group appeared a little blood in throat, the complication rate was 32% 12 cases in the laryngoscope group had complications, the complication rate was 107%( P＜ 005). Among it, 6 cases had the injury of tooth, tongue, gullet and larynx.The cases of reflexvomiting were 2,pulmonary ventilation by single lung were 1, intubation in esophagus were 2, cardiopulmonary arrest were 1.Conclusions:Endotracheal intubation under fiberoptic bronchoscope through mouth was accurate, the fewer complications and effective for patients, and could be used widely in clinical applications.
Objective To investigate the therapeutic effects of thyroid hormone replacement on critically ill COPD patients with low serum thyroid hormone. Methods Sixty-seven critically ill patients with acute exacerbation of COPD ( AECOPD) , and complicated with respiratory and/ or heart failure and low serum thyroid hormone, admitted from July 2008 to June 2011, were recruited for the study. They were randomly divided into an intervention group ( n = 34) and a control group ( n = 33) . The control group received conventional treatment and the intervention group received conventional treatment plus additional thyroid hormone replacement therapy. Results Compared with the control group, the overall efficacy of the intervention group was not significantly different ( 88. 2% vs. 81. 8% , P gt; 0. 05) , while average effective time was significantly shorter [ ( 9. 6 ±2. 5) d vs. ( 12. 3 ±2. 8) d, P lt; 0. 05] . The post-treatment serum FT3 , FT4 , TT4 , and h-TSH levels were significantly higher in the intervention group than those in the control group, and significantly higher than baseline ( P lt;0. 05) . Conclusions For AECOPD patients complicated with respiratory and/or heart failure and low serum thyroid hormone, thyroid hormone supplement at low dosage will help to improve serumthyroid hormone level, and promote early recovery.
ObjectiveTo investigate the correlation between compliance of clinical respiratory bundle and duration of mechanical ventilation.
MethodsThe data of patients who admitted to intensive care unit (ICU)of Cancer Hospital Chinese Academy of Medical Sciences between June 2013 and December 2014 were retrospectively reviewed and analyzed.The patients with respiratory insufficiency who ventilated more than 48 hours were included into the study.
ResultsFifty-five patients were enrolled into the final analysis.There were 43 males and 12 females with a mean age of 63.47±12.49 years.The mean sequential organ failure assessment (SOFA)score was 2.8±2.2,and the mean simplified acute physiology score 3 (SAPS3)was 51±14 on ICU admission.The mean duration of mechanical ventilation of all 55 patients was 7.3±5.5 days.The compliance of low tidal volume strategy was 23.6%(13/55).No significant difference was found on duration of mechanical ventilation between the patients who was compliant with low tidal volume strategy and the patients who was not compliant (7.31±7.02 days vs. 7.31±5.07 day,P=0.444).A negative correlation between compliance of protocolized sedation strategy and duration of mechanical ventilation was found by Bivariate spearman correlation analysis (r2=0.312,P<0.001).A negative correlation between compliance of spontaneous awakening trial strategy and duration of mechanical ventilation (r2=0.337,P<0.001)and a negative correlation between compliance of spontaneous breathing trial strategy and duration of mechanical ventilation (r2=0.280,P<0.001)were also found by Bivariate spearman correlation analysis.Multiple linear regression analysis showed that only spontaneous awakening trial strategy was correlated with duration of mechanical ventilation(B=-0.623,P<0.001).
ConclusionThe more compliance with clinical respiratory bundle,especially with spontaneous awakening trial strategy,the shorter of duration of mechanical ventilation.The effect of low tidal volume strategy on the duration of mechanical ventilation needs further studies.
【摘要】 目的 探討無創正壓通氣在慢性阻塞性肺疾病(COPD)合并Ⅱ型呼吸衰竭的治療作用。方法 2005年10月—2009年10月對COPD合并Ⅱ型呼吸衰竭患者40例,隨機分為對照組和治療組(各20例)。在行常規抗感染、對癥治療的同時,分別予以持續靜脈滴注尼可剎米或無創正壓通氣治療6 h,比較兩組治療前后生命體征及血氣分析變化。結果 治療6 h后,治療組在收縮壓、呼吸頻率及心率方面改善均顯著優于對照組(P＜005)。pH值對照組無改善,治療組顯著改善,兩組比較有統計學意義(P＜005)。治療后治療組動脈血氧分壓由(51.2±3.7) mm Hg上升至(82.3±5.7) mm Hg,對照組由(51.4±4.6) mm Hg上升至(66.7±8.3) mm Hg，治療組動脈血二氧化碳分壓由(78.9±10.0) mm Hg降低至(46.9±7.2) mm Hg,對照組由(78.6±6.5) mm Hg降低至(61.2±5.7) mm Hg,治療組改善明顯(P＜0.01)。結論 無創正壓通氣治療慢性阻塞性肺疾病合并Ⅱ型呼吸衰竭效果明顯。
Abstract： Objective To analyze risk factors associated with postoperative respiratory failure in patients with valvular surgery. Methods Between January 2001 and November 2010, clinical data of 618 patients with 339 males and 279 fameles at age of 10-74（44.01±13.95）years,undergoing valvular operations were investigated retrospectively. We divided the patients into two groups according to the presence （74 patients）or absence（544 patients）of postoperative respiratory failure. Its risk factors were evaluated by univariate and multivariate logistic regression analysis. Results The hospital mortality rate of valvular surgery was 6.1%（38/618）.The morbidity rate of respiratory failure was 12.0%（74/618） with hospital mortality rate at 17.6%（13/74） which was significantly higher than those patients without postoperative respiratory failure at 4.6%（25/544, χ2=18.994, P=0.000）. Univariate analysis showed age＞ 65 years（P=0.005）, New York Heart Association（NYHA）classⅣ（P=0.014）, election fraction＜ 50.0%（P=0.003）, cardiopulmonary bypass time＞ 3 h（P=0.001）, aortic cross clamping time＞ 2 h（P=0.008）, concomitant operation（ valvular operation with coronary artery bypass grafting, Bentall or radiofrequency ablation maze operation（P=0.000）, reoperation（P=0.012）, postoperative complications （P=0.000）, and blood transfusion＞ 2 000 ml（P=0.000） were important risk factors for postoperative respiratory failure. Multivariate logistic regression showed that concomitant operation（P=0.003）, reoperation（P=0.010）, postoperative complications（P=0.000）, and blood transfusion＞2 000 ml（P=0.012）were significant independent predictive risk factors. Conclusion This study suggest that patients with predictive risk factors of postoperative respiratory failure need more carefully treated. The morbidity of these patients would be reduced through improving perioperative management, shortening cardiopulmonary bypass time and reducing postoperative complications.
